ArticleExperimental and therapeutic medicine2023

Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.

Weitian Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.